Dulaglutide mitigates high dietary fructose-induced renal fibrosis in rats through suppressing epithelial-mesenchymal transition mediated by GSK-3β/TGF-β1/Smad3 signaling pathways.

Mohamad HE, Abdelhady MA, Abdel Aal SM, Elrashidy RA

Open source

DOI
10.1016/j.lfs.2022.120999
Published
2022 Nov 15
Container
Life sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lfs.2022.120999,
  title = {Dulaglutide mitigates high dietary fructose-induced renal fibrosis in rats through suppressing epithelial-mesenchymal transition mediated by GSK-3β/TGF-β1/Smad3 signaling pathways.},
  author = {Mohamad HE and Abdelhady MA and Abdel Aal SM and Elrashidy RA},
  year = {2022},
  journal = {Life sciences},
  doi = {10.1016/j.lfs.2022.120999},
  url = {https://doi.org/10.1016/j.lfs.2022.120999}
}

RIS

TY  - JOUR
TI  - Dulaglutide mitigates high dietary fructose-induced renal fibrosis in rats through suppressing epithelial-mesenchymal transition mediated by GSK-3β/TGF-β1/Smad3 signaling pathways.
AU  - Mohamad HE
AU  - Abdelhady MA
AU  - Abdel Aal SM
AU  - Elrashidy RA
PY  - 2022
JO  - Life sciences
DO  - 10.1016/j.lfs.2022.120999
UR  - https://doi.org/10.1016/j.lfs.2022.120999
ER  - 

APA

HE, M., MA, A., SM, A. A., & RA, E. (2022). Dulaglutide mitigates high dietary fructose-induced renal fibrosis in rats through suppressing epithelial-mesenchymal transition mediated by GSK-3β/TGF-β1/Smad3 signaling pathways.. Life sciences. https://doi.org/10.1016/j.lfs.2022.120999

Source records